130 related articles for article (PubMed ID: 38532545)
1. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study.
Duus AH; Hannibal CG; Baandrup L; Zheng G; Galanakis M; Maltesen T; Hertzum-Larsen R; Mørch LS; Kjær SK
Int J Cancer; 2024 Jul; 155(1):19-26. PubMed ID: 38532545
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of nonlocalized epithelial ovarian cancer among women using menopausal hormone therapy prior to diagnosis: The extreme study.
Baandrup L; Galanakis M; Hannibal CG; Dehlendorff C; Hertzum-Larsen R; Mørch LS; Kjaer SK
Int J Cancer; 2022 Nov; 151(9):1512-1522. PubMed ID: 35716136
[TBL] [Abstract][Full Text] [Related]
3. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.
Bešević J; Gunter MJ; Fortner RT; Tsilidis KK; Weiderpass E; Onland-Moret NC; Dossus L; Tjønneland A; Hansen L; Overvad K; Mesrine S; Baglietto L; Clavel-Chapelon F; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Agnoli C; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Jareid M; Quirós JR; Duell EJ; Sánchez MJ; Larrañaga N; Chirlaque MD; Barricarte A; Dias JA; Sonestedt E; Idahl A; Lundin E; Wareham NJ; Khaw KT; Travis RC; Rinaldi S; Romieu I; Riboli E; Merritt MA
Br J Cancer; 2015 Dec; 113(11):1622-31. PubMed ID: 26554655
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.
Brieger KK; Peterson S; Lee AW; Mukherjee B; Bakulski KM; Alimujiang A; Anton-Culver H; Anglesio MS; Bandera EV; Berchuck A; Bowtell DDL; Chenevix-Trench G; Cho KR; Cramer DW; DeFazio A; Doherty JA; Fortner RT; Garsed DW; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Høgdall E; Huntsman DG; Shen H; Jensen A; Johnatty SE; Jordan SJ; Kjaer SK; Kupryjanczyk J; Lambrechts D; McLean K; Menon U; Modugno F; Moysich K; Ness R; Ramus SJ; Richardson J; Risch H; Rossing MA; Trabert B; Wentzensen N; Ziogas A; Terry KL; Wu AH; Hanley GE; Pharoah P; Webb PM; Pike MC; Pearce CL;
Gynecol Oncol; 2020 Sep; 158(3):702-709. PubMed ID: 32641237
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer ꟷ The Extreme study.
Baandrup L; Dehlendorff C; Hertzum-Larsen R; Hannibal CG; Kjaer SK
Gynecol Oncol; 2021 May; 161(2):458-462. PubMed ID: 33583579
[TBL] [Abstract][Full Text] [Related]
9. History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme study.
Hannibal CG; Kjaer SK; Galanakis M; Hertzum-Larsen R; Maltesen T; Baandrup L
Gynecol Oncol; 2024 Mar; 182():1-6. PubMed ID: 38246041
[TBL] [Abstract][Full Text] [Related]
10. Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
Simin J; Tamimi RM; Callens S; Engstrand L; Brusselaers N
Int J Cancer; 2020 Jul; 147(1):33-44. PubMed ID: 31584190
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and ovarian cancer.
Mørch LS; Løkkegaard E; Andreasen AH; Krüger-Kjaer S; Lidegaard O
JAMA; 2009 Jul; 302(3):298-305. PubMed ID: 19602689
[TBL] [Abstract][Full Text] [Related]
12. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.
Greiser CM; Greiser EM; Dören M
Hum Reprod Update; 2005; 11(6):561-73. PubMed ID: 16150812
[TBL] [Abstract][Full Text] [Related]
13. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
14. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
15. Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea-based cohort study.
Yuk JS; Kim M
Menopause; 2023 May; 30(5):490-496. PubMed ID: 37022299
[TBL] [Abstract][Full Text] [Related]
16. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
17. Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium.
Petrick JL; Joslin CE; Johnson CE; Camacho TF; Peres LC; Bandera EV; Barnard ME; Beeghly A; Bethea TN; Dempsey LF; Guertin K; Harris HR; Moorman PG; Myers ER; Ochs-Balcom HM; Rosenow W; Setiawan VW; Wu AH; Schildkraut JM; Rosenberg L
Br J Cancer; 2023 Dec; 129(12):1956-1967. PubMed ID: 37865688
[TBL] [Abstract][Full Text] [Related]
18. Menopausal hormone therapy and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Doherty JA; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2548-56. PubMed ID: 18086757
[TBL] [Abstract][Full Text] [Related]
19. Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy.
Ring LL; Baandrup L; Zheng G; Gottschau M; Dehlendorff C; Mellemkjær L; Kjaer SK
Cancer Epidemiol; 2023 Jun; 84():102359. PubMed ID: 37054550
[TBL] [Abstract][Full Text] [Related]
20. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort.
Brinton LA; Schwartz L; Spitz MR; Park Y; Hollenbeck AR; Gierach GL
Cancer Causes Control; 2012 Mar; 23(3):487-96. PubMed ID: 22367699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]